Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C (MBL-HCV1)

This study has been terminated.
(The study was terminated due to funding constraints)
Sponsor:
Information provided by (Responsible Party):
MassBiologics
ClinicalTrials.gov Identifier:
NCT01532908
First received: February 10, 2012
Last updated: July 15, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: October 2016
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 13, 2016